Stock data
Arrowhead Pharmaceuticals, Inc. (ARWR)
Arrowhead Pharmaceuticals, Inc. (ARWR) reported revenue of US$829.45M and net income of -US$1.63M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-09-30
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$829.45M | — | US$98.35M | -US$1.63M | — |
| 2024 | US$3.55M | — | -US$601.08M | -US$599.49M | — |
| 2023 | US$240.74M | — | -US$205.00M | -US$205.28M | — |
| 2022 | US$243.23M | — | -US$178.51M | -US$176.06M | — |
| 2021 | US$138.29M | — | -US$149.04M | -US$140.85M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$75.25M | -US$194.28M | — |
| 2026-03-31 | US$73.74M | -US$132.73M | — |
| 2025-12-31 | US$264.03M | US$30.81M | — |
| 2025-09-30 | US$256.47M | -US$23.75M | — |
| 2025-06-30 | US$27.77M | -US$175.24M | — |
| 2025-03-31 | US$542.71M | US$370.44M | — |
| 2024-12-31 | US$2.50M | -US$173.09M | — |
| 2024-09-30 | US$0.00M | -US$170.54M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.